Literature DB >> 33806578

Occupational Exposure in the Lombardy Region (Italy) to SARS-CoV-2 Infection: Results from the MUSTANG-OCCUPATION-COVID-19 Study.

Paola Della Valle1,2, Marco Fabbri1,2, Fabiana Madotto2, Pietro Ferrara1,2, Paolo Cozzolino2, Elisabetta Calabretto2, Marco Italo D'Orso3, Ermanno Longhi2, Riccardo Polosa4,5, Michele Augusto Riva1, Giampiero Mazzaglia1, Carmen Sommese2, Lorenzo Giovanni Mantovani1,2.   

Abstract

Sero-epidemiological surveys are valuable attempts to estimate the circulation of SARS-CoV-2 in general or selected populations. Within this context, a prospective observational study was conducted to estimate the prevalence and persistence of SARS-CoV-2 antibodies in different categories of workers and factors associated with positivity, through the detection of virus-specific immunoglobulin G and M (IgG/IgM) in serum samples. Enrollees were divided in low exposure and medium-high groups on the basis of their work activity. Antibody responders were re-contacted after 3 months for the follow-up. Of 2255 sampled workers, 4.8% tested positive for SARS-CoV-2 IgG/IgM antibodies, with 81.7% to IgG only. Workers who continued to go to their place of work, were healthcare workers, or experienced at least one COVID-19-related symptom were more likely to test positive for SARS-CoV-2 antibodies. SARS-CoV-2 antibodies prevalence was significantly higher in the medium-high risk vs. low-risk group (7.2% vs. 3.0%, p < 0.0001). At 3-month follow-up, 81.3% of subjects still had antibody response. This study provided important information of SARS-CoV-2 infection prevalence among workers in northern Italy, where the impact of COVID-19 was particularly intense. The presented surveillance data give a contribution to refine current estimates of the disease burden expected from the SARS-CoV-2.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; antibody persistence; occupational exposure; seroprevalence

Mesh:

Substances:

Year:  2021        PMID: 33806578      PMCID: PMC7967539          DOI: 10.3390/ijerph18052567

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  26 in total

1.  Estimates of the initial impact of the COVID-19 epidemic on overall mortality: evidence from Italy.

Authors:  Sara Conti; Pietro Ferrara; Carla Fornari; Sergio Harari; Fabiana Madotto; Andrea Silenzi; Alberto Zucchi; Lamberto Manzoli; Lorenzo G Mantovani
Journal:  ERJ Open Res       Date:  2020-06-29

2.  Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19.

Authors:  F Javier Ibarrondo; Jennifer A Fulcher; David Goodman-Meza; Julie Elliott; Christian Hofmann; Mary A Hausner; Kathie G Ferbas; Nicole H Tobin; Grace M Aldrovandi; Otto O Yang
Journal:  N Engl J Med       Date:  2020-07-21       Impact factor: 91.245

3.  Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital.

Authors:  Alberto L Garcia-Basteiro; Gemma Moncunill; Marta Tortajada; Marta Vidal; Caterina Guinovart; Alfons Jiménez; Rebeca Santano; Sergi Sanz; Susana Méndez; Anna Llupià; Ruth Aguilar; Selena Alonso; Diana Barrios; Carlo Carolis; Pau Cisteró; Eugenia Chóliz; Angeline Cruz; Silvia Fochs; Chenjerai Jairoce; Jochen Hecht; Montserrat Lamoglia; Mikel J Martínez; Robert A Mitchell; Natalia Ortega; Nuria Pey; Laura Puyol; Marta Ribes; Neus Rosell; Patricia Sotomayor; Sara Torres; Sarah Williams; Sonia Barroso; Anna Vilella; José Muñoz; Antoni Trilla; Pilar Varela; Alfredo Mayor; Carlota Dobaño
Journal:  Nat Commun       Date:  2020-07-08       Impact factor: 14.919

4.  COVID-19 and healthcare systems: What should we do next?

Authors:  P Ferrara; L Albano
Journal:  Public Health       Date:  2020-05-22       Impact factor: 2.427

5.  Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?

Authors:  Konstantinos Farsalinos; Anastasia Barbouni; Raymond Niaura
Journal:  Intern Emerg Med       Date:  2020-05-09       Impact factor: 3.397

6.  Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients.

Authors:  Anita S Iyer; Forrest K Jones; Ariana Nodoushani; Jason B Harris; Richelle C Charles; Meagan Kelly; Margaret Becker; Damien Slater; Rachel Mills; Erica Teng; Mohammad Kamruzzaman; Wilfredo F Garcia-Beltran; Michael Astudillo; Diane Yang; Tyler E Miller; Elizabeth Oliver; Stephanie Fischinger; Caroline Atyeo; A John Iafrate; Stephen B Calderwood; Stephen A Lauer; Jingyou Yu; Zhenfeng Li; Jared Feldman; Blake M Hauser; Timothy M Caradonna; John A Branda; Sarah E Turbett; Regina C LaRocque; Guillaume Mellon; Dan H Barouch; Aaron G Schmidt; Andrew S Azman; Galit Alter; Edward T Ryan
Journal:  Sci Immunol       Date:  2020-10-08

7.  Risk of COVID-19 in health-care workers in Denmark: an observational cohort study.

Authors:  Kasper Iversen; Henning Bundgaard; Rasmus B Hasselbalch; Jonas H Kristensen; Pernille B Nielsen; Mia Pries-Heje; Andreas D Knudsen; Casper E Christensen; Kamille Fogh; Jakob B Norsk; Ove Andersen; Thea K Fischer; Claus Antonio Juul Jensen; Margit Larsen; Christian Torp-Pedersen; Jørgen Rungby; Sisse B Ditlev; Ida Hageman; Rasmus Møgelvang; Christoffer E Hother; Mikkel Gybel-Brask; Erik Sørensen; Lene Harritshøj; Fredrik Folke; Curt Sten; Thomas Benfield; Susanne Dam Nielsen; Henrik Ullum
Journal:  Lancet Infect Dis       Date:  2020-08-03       Impact factor: 25.071

8.  Humoral Immune Response to SARS-CoV-2 in Iceland.

Authors:  Daniel F Gudbjartsson; Gudmundur L Norddahl; Pall Melsted; Kristbjorg Gunnarsdottir; Hilma Holm; Elias Eythorsson; Asgeir O Arnthorsson; Dadi Helgason; Kristbjorg Bjarnadottir; Ragnar F Ingvarsson; Brynja Thorsteinsdottir; Steinunn Kristjansdottir; Kolbrun Birgisdottir; Anna M Kristinsdottir; Martin I Sigurdsson; Gudny A Arnadottir; Erna V Ivarsdottir; Margret Andresdottir; Frosti Jonsson; Arna B Agustsdottir; Jonas Berglund; Berglind Eiriksdottir; Run Fridriksdottir; Elisabet E Gardarsdottir; Magnus Gottfredsson; Olafia S Gretarsdottir; Steinunn Gudmundsdottir; Kjartan R Gudmundsson; Thora R Gunnarsdottir; Arnaldur Gylfason; Agnar Helgason; Brynjar O Jensson; Aslaug Jonasdottir; Hakon Jonsson; Thordur Kristjansson; Karl G Kristinsson; Droplaug N Magnusdottir; Olafur T Magnusson; Lovisa B Olafsdottir; Solvi Rognvaldsson; Louise le Roux; Gudrun Sigmundsdottir; Asgeir Sigurdsson; Gardar Sveinbjornsson; Kristin E Sveinsdottir; Maney Sveinsdottir; Emil A Thorarensen; Bjarni Thorbjornsson; Marianna Thordardottir; Jona Saemundsdottir; S Hjortur Kristjansson; Kamilla S Josefsdottir; Gisli Masson; Gudmundur Georgsson; Mar Kristjansson; Alma Moller; Runolfur Palsson; Thorolfur Gudnason; Unnur Thorsteinsdottir; Ingileif Jonsdottir; Patrick Sulem; Kari Stefansson
Journal:  N Engl J Med       Date:  2020-09-01       Impact factor: 91.245

9.  SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys.

Authors:  Pedro C Hallal; Fernando P Hartwig; Bernardo L Horta; Mariângela F Silveira; Claudio J Struchiner; Luís P Vidaletti; Nelson A Neumann; Lucia C Pellanda; Odir A Dellagostin; Marcelo N Burattini; Gabriel D Victora; Ana M B Menezes; Fernando C Barros; Aluísio J D Barros; Cesar G Victora
Journal:  Lancet Glob Health       Date:  2020-09-23       Impact factor: 26.763

10.  Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity.

Authors:  Carolyn Rydyznski Moderbacher; Sydney I Ramirez; Jennifer M Dan; Alba Grifoni; Kathryn M Hastie; Daniela Weiskopf; Simon Belanger; Robert K Abbott; Christina Kim; Jinyong Choi; Yu Kato; Eleanor G Crotty; Cheryl Kim; Stephen A Rawlings; Jose Mateus; Long Ping Victor Tse; April Frazier; Ralph Baric; Bjoern Peters; Jason Greenbaum; Erica Ollmann Saphire; Davey M Smith; Alessandro Sette; Shane Crotty
Journal:  Cell       Date:  2020-09-16       Impact factor: 66.850

View more
  10 in total

1.  The association between tobacco use and COVID-19 in Qatar.

Authors:  Ahmad AlMulla; Ravinder Mamtani; Sohaila Cheema; Patrick Maisonneuve; Joanne Daghfal; Silva Kouyoumjian
Journal:  Prev Med Rep       Date:  2022-05-19

2.  SARS-CoV-2 seroprevalence in healthcare workers and risk factors.

Authors:  Stéphanie Weber; Alice Didelot; Nelly Agrinier; Laurent Peyrin-Biroulet; Evelyne Schvoerer; Christian Rabaud; Hélène Jeulin
Journal:  Infect Dis Health       Date:  2022-05-17

3.  Seroepidemiological Survey on the Impact of Smoking on SARS-CoV-2 Infection and COVID-19 Outcomes: Protocol for the Troina Study.

Authors:  Riccardo Polosa; Venera Tomaselli; Pietro Ferrara; Alba Corina Romeo; Sonja Rust; Daniela Saitta; Filippo Caraci; Corrado Romano; Murugesan Thangaraju; Pietro Zuccarello; Jed Rose; Giulio Giacomo Cantone; Margherita Ferrante; Jonathan Belsey; Fabio Cibella; Elisa Interlandi; Raffaele Ferri
Journal:  JMIR Res Protoc       Date:  2021-11-22

4.  Seroprevalence of SARS-CoV-2 in a Large Cohort of Italian Police Officers.

Authors:  Sergio Garbarino; Alexander Domnich; Elisabetta Costa; Irene Giberti; Stefano Mosca; Cristiano Belfiore; Fabrizio Ciprani; Giancarlo Icardi
Journal:  Int J Environ Res Public Health       Date:  2021-11-20       Impact factor: 3.390

5.  An assessment of case-fatality and infection-fatality rates of first and second COVID-19 waves in Italy.

Authors:  Tommaso Filippini; Federico Zagnoli; Matteo Bosi; Maria Edvige Giannone; Cristina Marchesi; Marco Vinceti
Journal:  Acta Biomed       Date:  2021-10-01

6.  Seroepidemiology of SARS-CoV-2 in healthcare personnel working at the largest tertiary COVID-19 referral hospitals in Mexico City.

Authors:  Vanessa Dávila-Conn; Maribel Soto-Nava; Yanink N Caro-Vega; Héctor E Paz-Juárez; Pedro García-Esparza; Daniela Tapia-Trejo; Marissa Pérez-García; Pablo F Belaunzarán-Zamudio; Gustavo Reyes-Terán; Juan G Sierra-Madero; Arturo Galindo-Fraga; Santiago Ávila-Ríos
Journal:  PLoS One       Date:  2022-03-17       Impact factor: 3.240

7.  Occupation, work-related contact and SARS-CoV-2 anti-nucleocapsid serological status: findings from the Virus Watch prospective cohort study.

Authors:  Sarah Beale; Parth Patel; Alison Rodger; Isobel Braithwaite; Thomas Byrne; Wing Lam Erica Fong; Ellen Fragaszy; Cyril Geismar; Jana Kovar; Annalan Navaratnam; Vincent Nguyen; Madhumita Shrotri; Anna Aryee; Robert Aldridge; Andrew Hayward
Journal:  Occup Environ Med       Date:  2022-04-21       Impact factor: 4.948

8.  Seroprevalence of SARS-CoV-2 Infection Among Working Women and Impact of Workplace Restrictions.

Authors:  Moza Alishaq; Hanaa Nafady-Hego; Andrew Jeremijenko; Jameela Ali Al Ajmi; Mohamed Elgendy; Naser Ali Asad Al Ansari; Hamed Elgendy; Abdul-Badi Abou-Samra; Adeel A Butt
Journal:  Infect Drug Resist       Date:  2022-07-21       Impact factor: 4.177

9.  Time-Varying Effect of Hybrid Immunity on the Risk of Breakthrough Infection after Booster Dose of mRNA COVID-19 Vaccine: The MOSAICO Study.

Authors:  Pietro Ferrara; Domenico Ponticelli; Roberto Magliuolo; Mario Borrelli; Beniamino Schiavone; Lorenzo Giovanni Mantovani
Journal:  Vaccines (Basel)       Date:  2022-08-19

Review 10.  Temporal Dynamics of Socioeconomic Inequalities in COVID-19 Outcomes Over the Course of the Pandemic-A Scoping Review.

Authors:  Florian Beese; Julia Waldhauer; Lina Wollgast; Timo-Kolja Pförtner; Morten Wahrendorf; Sebastian Haller; Jens Hoebel; Benjamin Wachtler
Journal:  Int J Public Health       Date:  2022-08-29       Impact factor: 5.100

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.